Rchr
J-GLOBAL ID:201901017283955821   Update date: Feb. 01, 2024

HIROTA Akira

ヒロタ アキラ | HIROTA Akira
Research field  (1): Medical biochemistry
Research theme for competitive and other funds  (2):
  • 2021 - 2024 ES細胞・iPS細胞の機能制御を可能とする新規荷電性培養基板の開発
  • 2019 - 2021 Development of synthetic polymer gels that control the function of ES/iPS cells
Papers (5):
  • Masamichi Imajo, Akira Hirota, Shinya Tanaka. Generation of Fetal Intestinal Organoids and Their Maturation into Adult Intestinal Cells. Methods in Molecular Biology. 2023. 2650. 133-140
  • Akira Hirota, Jean-Emmanuel Clément, Satoshi Tanikawa, Takayuki Nonoyama, Tamiki Komatsuzaki, Jian Ping Gong, Shinya Tanaka, Masamichi Imajo. ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells. Cancers. 2022. 14. 23. 5890-5890
  • Hirota, A., AlMusawi, S., Nateri, A.S., Ordóñez-Morán, P., Imajo, M. Biomaterials for intestinal organoid technology and personalized disease modeling. Acta Biomaterialia. 2021. 132
  • Hirota, A., Nakajima-Koyama, M., Ashida, Y., Nishida, E. The nucleosome remodeling and deacetylase complex protein CHD4 regulates neural differentiation of mouse embryonic stem cells by down-regulating p53. Journal of Biological Chemistry. 2019. 294. 1. 195-209
  • Ashida, Y., Nakajima-Koyama, M., Hirota, A., Yamamoto, T., Nishida, E. Activin A in combination with ERK1/2 MAPK pathway inhibition sustains propagation of mouse embryonic stem cells. Genes to Cells. 2017. 22. 2. 189-202
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page